博晖创新(300318) - 2022 Q1 - 季度财报

Revenue and Profitability - The company's revenue for Q1 2022 was CNY 175,394,242.89, representing a 10.23% increase compared to CNY 159,118,438.30 in the same period last year[4] - The net profit attributable to shareholders was a loss of CNY 13,243,101.60, which is a 26.47% increase in loss compared to a loss of CNY 10,471,465.66 in the previous year[4] - The net profit for the current period is a loss of $26,680,596.65, compared to a loss of $21,160,208.78 in the previous period, reflecting a deterioration of approximately 26%[26] - The total comprehensive loss for the current period is $26,934,387.20, compared to a loss of $20,954,032.52 in the previous period, indicating an increase in losses of about 28.5%[26] Cash Flow and Operating Activities - The net cash flow from operating activities was a negative CNY 29,404,292.88, a decline of 138.79% from a negative CNY 12,313,915.41 in the same period last year[4] - The cash flow from operating activities shows a net outflow of $29,404,292.88, worsening from a net outflow of $12,313,915.41 in the previous period[28] - The company reported a cash inflow from financing activities of $132,357,092.92, compared to $127,719,272.37 in the previous period, showing a slight increase of about 3.5%[29] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,768,492,715.30, an increase of 2.13% from CNY 3,690,026,740.04 at the end of the previous year[5] - The total assets of Beijing Bohui Innovation Biotechnology Group Co., Ltd. as of March 31, 2022, amounted to CNY 3,768,492,715.30, an increase from CNY 3,690,026,740.04 at the beginning of the year[22] - Total liabilities rose to CNY 2,862,682,069.22 from CNY 2,757,281,706.76, an increase of about 3.8%[22] - The company's total equity decreased to CNY 905,810,646.08 from CNY 932,745,033.28, a decline of approximately 2.9%[22] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 50,030, with the largest shareholder holding 39.03% of the shares[13] Financial Ratios and Performance Metrics - The weighted average return on net assets was -1.37%, a decrease of 40.88% compared to -0.81% in the previous year[5] - Basic and diluted earnings per share for the current period are both -$0.0162, compared to -$0.0128 in the previous period, reflecting a decline in earnings[26] Expenses - The company reported a 68.18% increase in financial expenses, amounting to an increase of CNY 5,093,400, primarily due to increased interest-bearing liabilities to support project construction[9] - Total operating costs for the current period are $200,887,913.43, up from $177,047,246.72 in the previous period, indicating an increase of about 13.4%[25] - Research and development expenses for the current period are $13,783,836.86, down from $15,815,565.02 in the previous period, indicating a decrease of approximately 12.9%[25] Cash and Equivalents - The company's cash and cash equivalents increased to CNY 103,472,840.41 from CNY 39,394,993.04, representing a growth of approximately 163.5%[19] - Cash and cash equivalents at the end of the period amount to $99,811,835.38, an increase from $73,949,719.56 at the end of the previous period, representing a growth of about 35%[29] Inventory and Receivables - Accounts receivable decreased to CNY 88,325,335.14 from CNY 92,107,187.76, a decline of about 4.2%[19] - Inventory increased slightly to CNY 832,530,828.17 from CNY 820,953,599.87, reflecting a growth of approximately 1.7%[19] Non-Current Assets - The company’s non-current assets totaled CNY 2,610,191,804.91, showing a slight decrease from CNY 2,610,465,600.84[22] Short-Term Borrowings - The company’s short-term borrowings increased to CNY 438,304,359.67 from CNY 434,893,006.77, a rise of approximately 0.9%[22] Audit Status - The company has not undergone an audit for the first quarter report[30]